Alan S. Waggoner
Fondateur chez Sharp Edge Labs, Inc.
Profil
Alan S.
Waggoner is the founder.
He held the position of Member-Scientific Advisory Board at Acelerate, Inc. which was founded in 2004.
He also holds the position of Chief Architect at Sharp Edge Labs, Inc. which was founded in 2010.
Postes actifs de Alan S. Waggoner
Sociétés | Poste | Début |
---|---|---|
Sharp Edge Labs, Inc.
Sharp Edge Labs, Inc. Miscellaneous Commercial ServicesCommercial Services Sharp Edge Labs, Inc. develops biosensors to the cellular biology research community. It operates as a assay development company that offers products and services for drug discovery. The firm offers fluorogenic activating protein, which provides accurate and detailed detection method for cellular changes that is amendable to high-throughput screening and detailed follow-up. The company was founded by Alan S. Waggoner and Marcel P. Bruchez in 2010 and is headquartered in Pittsburgh, PA. | Fondateur | 01/01/2010 |
Anciens postes connus de Alan S. Waggoner
Sociétés | Poste | Fin |
---|---|---|
Acelerate, Inc.
Acelerate, Inc. BiotechnologyHealth Technology Acelerate, Inc. provides systems cell biology solutions. It address the problems of efficacy and toxicity with the cellular systems biology approach. The company was founded in 2004 and is headquartered in Pittsburgh, PA. | Fondateur | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 2 |
---|---|
Acelerate, Inc.
Acelerate, Inc. BiotechnologyHealth Technology Acelerate, Inc. provides systems cell biology solutions. It address the problems of efficacy and toxicity with the cellular systems biology approach. The company was founded in 2004 and is headquartered in Pittsburgh, PA. | Health Technology |
Sharp Edge Labs, Inc.
Sharp Edge Labs, Inc. Miscellaneous Commercial ServicesCommercial Services Sharp Edge Labs, Inc. develops biosensors to the cellular biology research community. It operates as a assay development company that offers products and services for drug discovery. The firm offers fluorogenic activating protein, which provides accurate and detailed detection method for cellular changes that is amendable to high-throughput screening and detailed follow-up. The company was founded by Alan S. Waggoner and Marcel P. Bruchez in 2010 and is headquartered in Pittsburgh, PA. | Commercial Services |